Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.72K Hold
90
﹤0.01% 351
2026
Q1
$4.97K Sell
90
-60
-40% -$3.25K ﹤0.01% 328
2025
Q4
$7.36K Buy
150
+100
+200% +$4.66K ﹤0.01% 302
2025
Q3
$2.16K Sell
50
-182
-78% -$7.11K ﹤0.01% 326
2025
Q2
$8.91K Buy
+232
New +$8.87K ﹤0.01% 268

Other funds holding GSK

Morse Asset Management's GSK Position: Q2 2026 in Review

Morse Asset Management held its GSK (GSK) position steady in Q2 2026 at 90 shares worth $4.72K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Morse Asset Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.91K in Q2 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Morse Asset Management held 90 shares of GSK worth $4.72K as of Q2 2026.
  • Morse Asset Management left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Morse Asset Management's portfolio in Q2 2026, its #351 holding.
  • Morse Asset Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • Morse Asset Management's GSK position peaked at $8.91K in Q2 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.